Key result
Higher circulating ADMA is linked to ~21% higher odds of prevalent atrial fibrillation.
Why the study?
The pathophysiological background of common AF is not well established despite its increasing prevalence and public health burden. Pathways involving oxidative stress, nitric oxide bioavailability, and methylated L-arginine metabolites are hypothesized to relate to AF in the general population.
Are circulating methylated L-arginine metabolites associated with intermediate electrocardiographic/echocardiographic phenotypes and prevalent atrial fibrillation in the general population?
Cohort (n=5,000)
Are circulating methylated L-arginine metabolites associated with intermediate electrocardiographic/echocardiographic phenotypes and prevalent atrial fibrillation in the general population?
Circulating methylated L-arginine metabolites (ADMA, NMMA, SDMA) show moderate associations with cardiac structural/electrical phenotypes and prevalent atrial fibrillation in the general population.
Answers are grounded in this paper and cite their sources.
May inform mechanistic AF research; leaves open clinical utility for risk stratification in the general population.
Background:The pathophysiological background of common atrial fibrillation (AF) is not well established despite its increasing prevalence in the general population and significant public health burden.Pathways of oxidative stress, nitric oxide bioavailability and L-arginine derivatives are hypothesized to be related to AF. Circulating methylated L-arginine metabolites can be assessed in the general population and may show an association with AF.Purpose: This study investigates correlations of methylated L-arginine metabolites and other diagnostic variables in the general population with AF.Methods: We determined L-arginine and its metabolites asymmetric dimethylarginine (ADMA), L-N-monomethylarginine (NMMA) and symmetric dimethylarginine (SDMA) in a large population-based study (n=5000), mean age 55±11 years, 51% men, in association with intermediate phenotypes of AF such as electrocardiographic and echocardiographic measures and manifest AF.Results: Individuals with AF (N=161), 71% men, were older, mean age 64.9± 8.3 years.In Bonferroni-corrected multivariable-adjusted regression analyses we observed moderate inverse associations for L-arginine, SDMA, and L-arginine/ ADMA ratio with ventricular heart rate, and for L-arginine and L-arginine/ADMA ratio with QTc interval.L-arginine was correlated with QRS duration.In echocardiographic analyses, SDMA was related to left atrial diameter, deceleration time and left ventricular ejection fraction, ADMA and NMMA were correlated with left ventricular mass.ADMA (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.04-1-41; P=0.01) and NMMA (OR 1.16, 95% CI 1.03-1.32,P=0.02) were related to prevalent AF.L-arginine/ADMA ratio was inversely associated (OR 0.8, 95% CI 0.65-0.98,P=0.03).Results were similar after adjustment for creatinine.Conclusions: In our large, population-based cohort, we observed moderate associations of L-arginine metabolites and intermediate electrocardiographic and echocardiographic variables and AF.Our findings support further investigations to define the role of L-arginine derivatives in AF and their clinical utility.
No takes yet. Share an insight, caveat, or question.
Capitan et al. (2015) conducted a cohort in Atrial fibrillation (n=5,000). Circulating methylated L-arginine metabolites (L-arginine, ADMA, NMMA, SDMA) was evaluated on Prevalent atrial fibrillation (OR 1.21, 95% CI 1.04-1.41, p=0.01). Circulating ADMA and NMMA were positively associated with prevalent atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: